Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Johnson & Johnson, a leading name in the research and development services sector, is headquartered in the United States. Founded in 1886, the company has established itself as a pioneer in healthcare innovation, focusing on pharmaceuticals, medical devices, and consumer health products. With a strong presence in North America, Europe, and Asia, Johnson & Johnson is renowned for its commitment to quality and safety.
The company’s core offerings include advanced medical technologies, over-the-counter consumer health products, and prescription medications, each distinguished by rigorous research and development. Notable achievements include the development of groundbreaking treatments and a robust portfolio of trusted brands. As a market leader, Johnson & Johnson continues to shape the future of healthcare through its dedication to improving patient outcomes and enhancing quality of life.
+37 vs industry average
Johnson And Johnson’s score of 70 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Johnson & Johnson, a US-based research and development services company, reported total carbon emissions of approximately 6.5 billion kg CO2e in 2024. This figure includes Scope 1 emissions of approximately 314.7 million kg CO2e, Scope 2 market-based emissions of approximately 116.2 million kg CO2e, and Scope 3 emissions of about 6.07 billion kg CO2e. In 2023, the company's total emissions were approximately 6.25 billion kg CO2e.
Johnson & Johnson has set several climate commitments. The company aims to achieve carbon neutrality for its operations (Scope 1 and 2) by 2030. They have committed to reducing absolute Scope 1 and 2 GHG emissions by 44% by 2030, using a 2021 base year. Additionally, Johnson & Johnson targets a 20% reduction in absolute upstream Scope 3 GHG emissions over the same period. Earlier commitments included a 60% reduction in absolute Scope 1 and 2 GHG emissions by 2030 from a 2016 base year, and an 80% reduction in absolute carbon emissions by 2050 from a 2010 baseline. Johnson & Johnson also commits that 80% of its suppliers, by emissions covering purchased goods and services and upstream transportation and distribution, will have science-based targets by 2028.
2030
44% reduction in Scope 2
Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* Johnson & Johnson also commits…
2030
44% reduction in Scope 1
Johnson & Johnson commits to reduce absolute scope 1 and 2 GHG emissions 44% by 2030 from a 2021 base year.* Johnson & Johnson also commits…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Johnson And Johnson’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more